MOTS-c: What the Research Shows

Research Use Only: This article summarises published scientific literature for laboratory and research audiences. It is not medical advice, and MOTS-c is not approved for human or veterinary use.

What is MOTS-c?

MOTS-c is a mitochondrial-derived peptide (MDP), meaning it is encoded within mitochondrial DNA rather than the cell nucleus. It is one of the most studied members of this emerging peptide class and is examined in the research literature for its role in metabolic signalling.

Where MOTS-c sits in the research literature

The evidence base is largely preclinical, based on cell and animal studies of metabolism and mitochondrial biology. MOTS-c is a comparatively recent research topic, and laboratory findings should not be extrapolated to people.

Reported areas of preclinical interest

• Metabolic signalling: studied for effects on AMPK and metabolic-stress pathways in laboratory models.
• Mitochondrial biology: examined as a mitochondrial-derived peptide in cell research.

Why the “research use only” label matters

MOTS-c is supplied as a research material and is intended strictly for laboratory and scientific research, not for human or veterinary consumption.

Handling and storage

Store lyophilised peptide cool, dry and away from light, and refrigerate reconstituted solution, using it within the indicated stability window. Follow the documentation supplied with each batch.

Frequently asked questions

What is MOTS-c studied for?

It is studied in laboratory models of metabolism and mitochondrial biology as a mitochondrial-derived peptide.

Is MOTS-c approved for human use?

No. It is a research material only and is not intended for human or veterinary use.

Key takeaways

MOTS-c is a mitochondrial-derived peptide and an emerging research topic in metabolic and mitochondrial biology. It is a research material only. Review the MOTS-c research product.

References

References sourced via PubMed.

1. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metab. 2015;21(3):443-454. DOI · PubMed 25738459.
2. Zheng Y, Wei Z, Wang T. MOTS-c: a promising mitochondrial-derived peptide for therapeutic exploitation. Front Endocrinol (Lausanne). 2023;14:1120533. DOI · PubMed 36761202.

Disclaimer: This article is for informational and educational purposes for a research audience. It is not medical advice. Products referenced are sold strictly for laboratory research and are not for human or veterinary use.